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Stroke Quality Measures in Mexican Americans and Non-Hispanic Whites
Abstract
Mexican Americans (MAs) have been shown to have worse outcomes after stroke than non-Hispanic
Whites (NHWs), but it is unknown if ethnic differences in stroke quality of care may contribute to these
worse outcomes. We investigated ethnic differences in the quality of inpatient stroke care between MAs
and NHWs within the population-based prospective Brain Attack Surveillance in Corpus Christi (BASIC)
Project (February 2009- June 2012). Quality measures for inpatient stroke care, based on the 2008 Joint
Commission Primary Stroke Center definitions were assessed from the medical record by a trained
abstractor. Two summary measure of overall quality were also created (binary measure of defect-free
care and the proportion of measures achieved for which the patient was eligible). 757 individuals were
included (480 MAs and 277 NHWs). MAs were younger, more likely to have hypertension and diabetes,
and less likely to have atrial fibrillation than NHWs. MAs were less likely than NHWs to receive tPA (RR:
0.72, 95% confidence interval (CI) 0.52, 0.98), and MAs with atrial fibrillation were less likely to receive
anticoagulant medications at discharge than NHWs (RR 0.73, 95% CI 0.58, 0.94). There were no ethnic
differences in the other individual quality measures, or in the two summary measures assessing overall
quality. In conclusion, there were no ethnic differences in the overall quality of stroke care between MAs
and NHWs, though ethnic differences were seen in the proportion of patients who received tPA and
anticoagulant at discharge for atrial fibrillation.
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ABSTRACT
Mexican Americans (MAs) have been shown to have worse outcomes after stroke than
non-Hispanic Whites (NHWs), but it is unknown if ethnic differences in stroke quality of
care may contribute to these worse outcomes. We investigated ethnic differences in the
quality of inpatient stroke care between MAs and NHWs within the population-based
prospective Brain Attack Surveillance in Corpus Christi (BASIC) Project (February
2009- June 2012). Quality measures for inpatient stroke care, based on the 2008 Joint
Commission Primary Stroke Center definitions were assessed from the medical record by
a trained abstractor. Two summary measure of overall quality were also created (binary
measure of defect-free care and the proportion of measures achieved for which the patient
was eligible). 757 individuals were included (480 MAs and 277 NHWs). MAs were
younger, more likely to have hypertension and diabetes, and less likely to have atrial
fibrillation than NHWs. MAs were less likely than NHWs to receive tPA (RR: 0.72, 95%
confidence interval (CI) 0.52, 0.98), and MAs with atrial fibrillation were less likely to
receive anticoagulant medications at discharge than NHWs (RR 0.73, 95% CI 0.58, 0.94).
There were no ethnic differences in the other individual quality measures, or in the two
summary measures assessing overall quality. In conclusion, there were no ethnic
differences in the overall quality of stroke care between MAs and NHWs, though ethnic
differences were seen in the proportion of patients who received tPA and anticoagulant at
discharge for atrial fibrillation.
Keywords: Stroke; Quality of Health Care; Mexican Americans; Thrombolysis;
Anticoagulants
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INTRODUCTION
Hispanics are now the largest minority population in the United States, with Mexican
Americans (MAs) making up the largest sub-population.(United States Census Bureau, 2013)
MAs have a higher risk of incident and recurrent stroke compared with non-Hispanic Whites
(NHWs), and also have worse functional outcomes after stroke.(Lisabeth et al., 2014; Lisabeth et
al., 2006; Morgenstern et al., 2013) Racial and ethnic disparities in stroke quality measures have
been previously reported, though most studies have focused on differences involving African
Americans, with relatively few studies specifically focused on Hispanic/Latino
populations.(Cruz-Flores et al., 2011; Jacobs et al., 2006; Kelly, Hellkamp, Olson, Smith, &
Schwamm, 2012; Reeves et al., 2010; Schwamm et al., 2010) One study based on the Get with
the Guidelines (GWTG) database that did separately analyze Hispanics from other race-ethnic
groups found few overall differences in stroke quality of care between Hispanics and nonHispanic whites (NHWs), though Hispanics were less likely to have counseling for smoking
cessation and discharge anti-thrombotics when adjusted for patient and hospital
characteristics.(Schwamm et al., 2010) However, it is unknown if these findings are consistent in
other health systems that do not participate in GWTG, within specific Hispanic sub-populations,
or when addressed in a community-based study.
Investigation of potential ethnic differences in quality of care specifically between MAs
and NHWs is warranted to determine if the observed ethnic differences in outcomes may be due
to ethnic disparities in quality of stroke care. We investigated ethnic differences in the quality of
inpatient stroke care in a population-based study in a bi-ethnic community without an academic
medical center.
METHODS
Study population and case identification
This study was a pre-planned cross-sectional analysis from the prospective Brain Attack
Surveillance in Corpus Christi (BASIC) Project. Detailed study methods have been previously
reported.(Morgenstern et al., 2013) Briefly, active and passive surveillance were used to identify
cases of stroke >44 years old presenting to one of six hospitals in Nueces County, Texas. This is
a predominantly urban, bi-ethnic, non-immigrant community where the majority (62%) of
residents are of MA descent(United States Census Bureau, 2014) and are second or third
generation US residents. The six acute care hospitals (median bed size 154, range 72-345) in the
community all have CT, MRI and neurology services. Two of the hospitals were certified by the
Joint Commission as Primary Stroke Centers (one in January 2009 and the other in December
2010). Stroke diagnosis was validated by study physicians using source documentation blinded
to ethnicity and age. Eligibility criteria for the current study included individuals with ischemic
stroke presenting between February, 2009 and June, 2012. Ethnicity was determined from the
medical record as we have previously reported high agreement between medical record and selfreport in this community.(Morgenstern et al., 2004) Only individuals of NHW or MA ethnicity
were included due to low numbers of individuals in other race-ethnic groups. If an individual had
multiple events during the study period, only the first ischemic stroke was included. This study
was approved by the Institutional Review Board of the University of Michigan (approval number
HUM00041536) as well as the local Corpus Christi hospital systems. Screening the medical
record for stroke cases was approved under a waiver of informed consent, with written consent
obtained for detailed medical record review and interviews.
Medical record review and quality measures
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Trained abstractors reviewed the medical record for key clinical characteristics. Initial
National Institutes of Health Stroke Scale (NIHSS) was determined from the medical record or
abstracted from the chart based on a previously validated method.(L. S. Williams, Yilmaz, &
Lopez-Yunez, 2000) Highest level of education was assessed based on interview with the patient
or proxy, as was pre-stroke disability (based on a published structured interview for the Modified
Rankin Scale.(Wilson et al., 2002)) Health insurance status was determined from medical record
review. The number of comorbid conditions was determined from the medical record and
summed to create a comorbidity index for each patient (range 0-15).
Stroke quality measures were determined from the medical record by a trained abstractor,
adapted from the 2008 Joint Commission Primary Stroke Center definitions. Data were collected
on the following measures: 1) deep vein thrombosis prophylaxis; 2) discharged on
antithrombotic therapy; 3) patients with atrial fibrillation receiving anticoagulation therapy at
discharge; 4) thrombolytic therapy administered; 5) antithrombotic therapy by the end of hospital
day 2; 6) discharged on cholesterol reducing medication; and 7) assessed for rehabilitation.
Transferred patients had the quality measure attributed to the discharging hospital. Two
summary measures of the overall quality of care were used.(Peterson et al., 2010) A composite
opportunity score was created by dividing the number of performance measures that a patient
met by the number of measures they were eligible for, such that the final score ranged from 0 to
1. A binary defect-free care variable was defined as a patient meeting all of the eligible
performance measures. A reliability study of the individual quality measures was performed by
having a second abstractor review a sample of 29 cases as described in the Appendix. The mean
percent agreement was 92% (range 83-100%) for determination of inclusion/exclusion in the
denominators and 97% (range 88% to 100%) for determination of inclusion/exclusion in the
numerators.
Statistical Analysis
Descriptive statistics were calculated for all variables; differences by ethnicity were
assessed using chi-square tests for categorical and Kruskal-Wallis tests for continuous variables.
To examine ethnic differences in quality of care measures, we fit a Poisson model (unadjusted)
with robust standard errors to report relative risk for the binary outcomes and a linear model
(unadjusted) with robust standard errors for the continuous composite score. To account for
hospital clustering, we then used generalized estimating equations (GEE) with a log link function
for the binary outcomes (Lu & Tilley, 2001) and GEE with the identity link function for the
continuous outcome, and robust standard errors were additionally corrected for the small number
of clusters used (n=6 hospitals).(Mancl & DeRouen, 2001) Adjustment for hospital clustering
was not performed for the tPA and anticoagulant for atrial fibrillation measures due to small
numbers of eligible participants for these measures at some of the hospitals. In order to assess the
effect of potential confounders of any observed ethnic differences in the quality measures, we
sequentially added covariates to the regression models for each of the individual and overall
quality measures, beginning with an unadjusted model including ethnicity alone (model 1), next
adding in hospital clustering (model 2, except for tPA and atrial fibrillation measures as noted
above), and then demographics including age and sex (model 3). To avoid overfitting the model,
no additional adjustment was performed for the individual quality indicators due to the low
number of outcome events per variable.(Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996)
However, for the two overall quality measures where there were a larger number of outcome
events per variable, a final fully adjusted model (model 4) was developed to additionally adjust
for education, insurance, pre-stroke disability (Modified Rankin 0-2 versus 3-5), NIHSS, and
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comorbidity index. To estimate the impact of hospital system on quality, the absolute values for
the intraclass correlation coefficients (ICC) were calculated from the hierarchical models (i.e.,
model 2) for the two overall quality outcomes. The functional form of continuous covariates
(age, NIHSS) was assessed. Due to non-linear associations with outcome, age was modeled with
quadratic term for the composite opportunity score and NIHSS was log transformed and modeled
with a quadratic term for both overall quality measures.
RESULTS
A total of 844 individuals with ischemic stroke were identified during the study period,
with 79 cases excluded for race-ethnicity other than MA or NHW, 5 excluded as not eligible for
any quality measure, and 3 excluded due to missing covariates (2 for education and 1 for
comorbidity index), leaving a total of 757 individuals available for analysis. Descriptive
characteristics and stroke risk factors by ethnicity are shown in Table 1. MAs were younger,
more likely to have hypertension and diabetes, and less likely to have atrial fibrillation than
NHWs. Education and insurance were also different by ethnicity. There were no ethnic
differences in the initial NIHSS, comorbidity index, or in-hospital mortality.
Table 1: Descriptive characteristics of the population overall and by ethnicity
Non-Hispanic
Mexican
White
American
Characteristic
N=277
N=480
(% unless
(% unless
specified)
specified)
Median Age (Q1, Q3)
72 (60, 82)
66 (57,78)
Female Sex
52.3
51.3
Hypertension
75.1
85.8
Diabetes
28.2
59.8
Prior stroke or TIA
30.7
33.5
High cholesterol
49.5
45.6
Atrial fibrillation
21.7
11.0
CAD or MI
30.0
34.8
Smoker
45.8
29.0
Median Comorbidity index (Q1, Q3)
3 (2, 5)
3 (2, 5)
Median NIHSS (Q1, Q3)
4 (2,10)
4 (2,9)
Baseline MRS 0-2
76.5
75.2
In-hospital death
3.6
3.1
Education
Less than High school
13.7
52.7
High school
31.4
26.0
Vocational/some college
27.8
13.3
College or more
27.1
7.9
Insurance
Self pay
12.3
16.9
Medicare, Medicaid and Medicare,
15.9
24.4
or Veterans Affairs
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Medicaid
Private, Private and Medicare

1.4
70.4

3.3
55.4

MA indicates Mexican American; NHW, non-Hispanic white; mRS, modified Rankin scale; TIA, transient ischemic
attack; CAD, coronary artery disease; MI, myocardial infarction; and NIHSS, National Institute for Health Stroke
Scale.

A descriptive summary for the individual quality measures and the two summary quality
measures by ethnicity are reported in Table 2. Most of the individual measures were met in 80%
or more of cases; exceptions included DVT prophylaxis (79.0% overall) anticoagulant at
discharge for atrial fibrillation (70.1% overall), and acute stroke therapy with tPA administered
(62.2% overall).
Table 2: Quality indicators, overall and by ethnicity
Non-Hispanic
White (N=277)
Quality indicator
N/D or
% or
median
Q1, Q3
Deep vein
thrombosis
154/195
79.0
prophylaxis at 48
hours
Discharged on
211/249
84.7
antithrombotic
Anticoagulant at
discharge for atrial
53/66
80.3
fibrillation
tPA administered
27/36
75.0
Antithrombotic at
228/241
94.6
48 hours
Cholesterol
medication at
149/193
77.2
discharge
Rehabilitation
223/229
97.4
evaluation
Summary measures
Defect Free Care
161/277
58.1
Median composite
1.0
(0.8,1.0)
score (Q1, Q3)

Mexican American
(N=480)
N/D or
% or
median
Q1, Q3
261/330

79.1

377/435

86.7

36/61

59.0

29/54

53.7

405/434

93.3

273/331

82.5

389/407

95.6

284/480

59.2

1

(0.8,1.0)

*N/D indicates Numerator/Denominator, e.g. number of patients attaining the quality measure over the number of
patients eligible for the quality measure.

The regression models investigating ethnic differences in the individual indicators are shown in
Table 3. Most of the individual measures did not show differences by ethnicity. However, MAs
were less likely than NHWs to receive tPA (relative risk (RR) 0.72, 95% confidence interval (CI)
0.52, 0.98). Similarly, MAs with atrial fibrillation were less likely to receive anticoagulant
medications at discharge when compared with NHWs (RR 0.73, 95% CI 0.58, 0.94). There were
no ethnic differences in any of the other individual quality indicators. Note that the sequential
model building (adding adjustment for hospital clustering when appropriate and then age and
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sex) did not result in any meaningful changes in the magnitude of the association between
ethnicity and any of the quality measures.
Table 3: Association of Mexican American ethnicity with individual quality indicators
Model 2: Add
Model 1:
Model 3: Add
hospital
age* and sex
Unadjusted
clustering
Quality indicator
RR for MA†
RR for MA†
RR for MA†
(95%CI)
(95% CI)
(95% CI)
Deep vein thrombosis
1.00
1.00
1.00
prophylaxis at 48 hours
(0.91, 1.10)
(0.90,1.11)
(0.94, 1.06)
Discharged on
1.02
1.02
1.01
antithrombotic
(0.96, 1.09)
(0.88, 1.19)
(0.89, 1.15)
Anticoagulant at discharge
0.73
0.74
‡
for atrial fibrillation
(0.58, 0.94)
(0.58, 0.94)
0.72
0.70
tPA administered‡
(0.52, 0.98)
(0.51, 0.96)
0.99
0.99
0.98
Antithrombotic at 48 hours
(0.95, 1.03)
(0.96, 1.01)
(0.94, 1.02)
Cholesterol medication at
1.07
1.06
1.05
discharge
(0.98, 1.17)
(0.99, 1.13)
(0.97, 1.13)
0.98
0.97
0.97
Rehabilitation evaluation
(0.95, 1.01)
(0.88, 1.07)
(0.88, 1.08)
MA indicates Mexican American; RR, Relative Risk; and CI, confidence interval
*Age was modeled as a linear term.
†
Reference group for Mexican American was non-Hispanic white.
‡
Unable to adjust for hospital clustering due to small sample size for these quality measures, therefore model 3
includes only age, ethnicity, and sex as covariates.

The findings for the regression models for the two overall summary indicators are shown
in Table 4. The absolute values for ICC for the hospital effect were < 0.01 for both the composite
score and defect-free care, suggesting that there was little difference in quality across hospitals.
For the composite quality score, ethnicity was not associated with quality in the unadjusted or
adjusted models. Factors significantly associated with better quality of care in the fully-adjusted
composite model included younger age, male sex, insurance, education, baseline modified
Rankin of 0-2, and stroke severity. For the defect-free care measure, there was also no ethnic
difference in quality in either the unadjusted or fully adjusted models. Factors associated with
defect free care in the fully-adjusted model included younger age, male sex, lower comorbidity
index, insurance, education, and stroke severity.
Table 4: Overall quality of care measures by ethnicity
Model 1*
Model 2†
Estimate or RR
(95%CI)

Estimate or RR
(95%CI)

Model 3‡

Model 4§

Estimate or RR
(95%CI)

Estimate or RR
(95%CI)

Composite Quality Score
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Estimate
-0.004
for MA
(-0.034, 0.026)
Defect Free Care
RR for
1.01
MA
(0.94, 1.09)

-0.003
(-0.034, 0.028)

-0.01
(-0.026, 0.005)

-0.016
(-0.064, 0.032)

1.02
(0.82, 1.27)

0.99
(0.90, 1.10)

0.97
(0.86, 1.09)

MA indicates Mexican American; RR, Relative Risk; and CI, confidence interval.
Reference group for Mexican American was non-Hispanic white.
*Model 1: Unadjusted (ethnicity alone)
†
Model 2: Add hospital clustering
‡
Model 3: Add in age (linear term for the defect free and quadratic term for the composite score), and sex
§
Model 4: Add education, insurance, pre-stroke disability (Modified Rankin 0-2 versus 3-5), National Institutes of
Health Stroke Scale (log transformed and quadratic), and comorbidity index

DISCUSSION
We found no difference in the overall quality of stroke care provided between MAs and
NHWs in this community using a measure of defect free care and a composite quality score.
However, there were differences in some of the individual quality indictors, with MAs less likely
than NHWs to receive intravenous tPA and to receive anticoagulant medications at discharge in
the setting of atrial fibrillation. While the lack of difference in overall quality is reassuring, it is
concerning that the magnitude of the ethnic differences seen in the tPA and discharge
anticoagulant measures was quite large, with MAs about 30% less likely than NHWs to meet
these measures. While the differences in tPA and discharge anticoagulant are potentially
important and could contribute to health disparities between MAs and NHWs,(Lisabeth et al.,
2014; Lisabeth et al., 2006) it seems unlikely that these two quality measures would entirely
explain the observed ethnic differences in functional outcome and stroke recurrence, as less than
20% of patients were eligible for each of these measures.
There are a limited number of prior studies that have investigated the quality of stroke
care among Hispanics.(Cruz-Flores et al., 2011) The largest study that specifically compared
quality of care between Hispanics and NHWs was based on the GWTG data.(Schwamm et al.,
2010) Our study differs from the in the GWTG dataset as it is a population-based sample from a
community with a large, non-immigrant MA population. Similar to our study, the GWTG
investigators found no difference in the overall quality of care between Hispanics and NHWs
using a defect-free care measure. They did identify some statistically significant, but small
absolute ethnic differences in individual quality indicators, with Hispanics less likely to receive
discharge antithrombotics and smoking cessation counseling, but no differences were seen in
other measures including tPA and anticoagulation for atrial fibrillation.(Schwamm et al., 2010)
Our study adds to this prior work by specifically focusing on MAs, the largest sub-population of
Hispanics, and identifies several areas of potentially large ethnic disparities in quality of stroke
care in this community.
Examining the issue of discharge anticoagulant for atrial fibrillation in more detail, a
prior study of nursing home residents found that Hispanics with stroke and an indication for
anticoagulation were less likely than NHWs to receive warfarin, though this difference was
attenuated when adjusting for demographics and other risk factors.(Christian, Lapane, & Toppa,
2003) In BASIC, we have previously reported that MAs are more likely than NHWs to have a
recurrent stroke in the setting of atrial fibrillation, and that the recurrent strokes tended to be
more severe among MAs.(Simpson et al., 2010) This prior analysis did not identify any ethnic
difference in the proportion of patients discharged on warfarin, though the use of warfarin at
discharge was low in both ethnic groups (<40%). The prior analysis was based on an earlier time
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period (2000-2008) and had other minor methodological differences that complicate a direct
comparison of results, though these two analyses suggest a worrisome pattern of disparities in
the care of MA stroke patients with atrial fibrillation. This disparity is likely to be of increasing
importance given the growing population of older MAs.(Vincent & Velkoff, 2010)
Our findings on the tPA and discharge anticoagulant measures should be interpreted with
a degree of caution, as these two indicators had the smallest number of eligible individuals (90
for tPA and 127 for discharge anticoagulant) compared with other quality indicators, and
therefore our ability to adjust for confounders was limited. Since these quality measures are
designed by definition to identify only individuals eligible for the particular therapy, the
unadjusted result is arguably the more important finding than the adjusted result, and it is the
unadjusted raw proportion that is subject to public reporting of hospital outcomes. Therefore,
identifying potential confounders of the ethnicity-quality relationship is useful to explain the
reason for the disparity, but does not diminish the importance of the observed unadjusted ethnic
difference in quality. Still, given the relatively small sample, further confirmation of these
findings in other populations is warranted.
Other studies have suggested that hospital differences may be an important determinant
of variability in quality of care.(Reeves et al., 2010; Schwamm et al., 2010) We found no
evidence of an effect of hospital-level differences in quality of care in this community, as the
hospital level ICC was quite small for the two overall quality measures. It is worth noting that
the majority of cases in this study came from a single hospital, which may have limited our
ability to detect hospital-level differences. Additionally, this is a smaller community relative to
other reports (6 hospitals), and therefore quality may be more homogenous within the
community. Two of the six hospitals in this community are certified as primary stroke centers,
with one obtaining certification in January 2009 and the other in December 2010. Since our data
collection started in February 2009, we did not formally investigate the effect of stroke center
certification on quality due to low number of pre-certification cases available in these hospitals.
This study has limitations. While the quality measures were based on 2008 JC measures,
minor adaptations to the quality measures were needed for the current study. As with any process
measure, we cannot be certain if these differences are due to a true difference in treatment versus
simply an artifact of differences in documentation of care. However, accurate documentation is
one important dimension of quality, especially now with public reporting of stroke quality
measures.
CONCLUSION
MAs were less likely than NHWs to receive certain recommended stroke treatments
including intravenous tPA and anticoagulant medication at discharge for atrial fibrillation. While
there was no ethnic difference in the overall quality of care provided, further investigation of
these particular measures where larger differences were identified is warranted in order to design
interventions to eliminate these disparities.
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APPENDIX: RELIABILITY OF QUALITY MEASURES
A random sample of thirty stroke cases for the time period 2011-2012 was selected for
the reliability study. One case was ineligible due to a change in validation status leaving 29 cases
eligible for the reliability study. Data elements for all quality measures were re-abstracted from
the medical record by a second abstractor blinded to the prior assessment and compared to the
original data. Reliability was considered in two ways following methods previously published
for assessing the reliability of standardized performance measures.(S. C. Williams, Watt,
Schmaltz, Koss, & Loeb, 2006) First, agreement was assessed for determination of whether a
patient was included or excluded from the denominator for each quality measure (i.e., the quality
measure population). Second, agreement was assessed for determination of whether a patient was
included or excluded from the numerator for each quality measure, given that both raters
included the patient in the denominator for that measure. Agreement was calculated as percent
agreement, percent positive agreement, and percent negative agreement using the formulas
outlined below.(Cicchetti & Feinstein, 1990) Kappa was not calculated given the imbalance in
the marginal totals of the two by two tables for the quality measures which has been shown to
result in artificially low estimates of kappa despite high agreement.(Cicchetti & Feinstein, 1990)

Proportion of positive agreement
Proportion of negative agreement
Proportion of observed agreement

2*a/(N+a-d)
2*d/(N-a+d)
(a+d)/N

In 2X2 table, a, b, c, d
represent frequency of
each cell
a b
c d
N = a+b+c+d

Results of the reliability study are included in Appendix Table 1 (denominators) and Appendix
Table 2 (numerators). Percent agreement for determination of whether patients were
included/excluded from the denominator for the quality measures ranged from 83% for deep vein
thrombosis (DVT) prophylaxis to 100% for thrombolytic therapy administered (tPA). Percent
agreement for determination of whether patients were included/excluded from the numerator for
the quality measures ranged from 88% for antithrombotic at discharger to 100% for several of
the measures (DVT prophylaxis, discharged on cholesterol reducing medication, patients with
atrial fibrillation receiving anticoagulation therapy at discharge, tPA).
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Appendix Table 1: Comparison of originally abstracted and re-abstracted data for determination
of inclusion/exclusion in the denominator of the quality measure.
Reabstracted
data
Observed
Proportion Proportion
Original
proportion
of positive of negative
data
of
agreement agreement
Quality measure
Yes No agreement
Yes
20
5
DVT prophylaxis
0.83
0.89
0.62
at 48 hours
No
0
4
Discharged on
Yes
24
1
0.90
0.94
0.57
antithrombotic
No
2
2
Anticoagulant at
Yes
4
0
0.97
0.89
0.98
discharge for afib
No
1
24
tPA administered
Yes
4
0
1.00
1.00
1.00
No
0
25
Antithrombotic at
Yes
26
2
0.93
0.96
0.50
48 hours
No
0
1
Cholesterol
Yes
16
1
medication at
0.93
0.94
0.92
discharge
No
1
11
Rehabilitation
Yes
24
3
0.90
0.94
0.57
evaluation
No
0
2
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Appendix Table 2: Comparison of originally abstracted and re-abstracted data for determination
of inclusion/exclusion in the numerator* of the quality measure.
Reabstracted
data
Observed
Proportion Proportion
Original
proportion
of positive of negative
data
of
agreement agreement
Quality measure
Yes No agreement
Yes
18
0
DVT prophylaxis
at 48 hours
No
0
2
1.00
1.00
1.00
Discharged on
Yes
18
1
antithrombotic
No
0
5
0.96
0.97
0.91
Anticoagulant at
Yes
4
0
discharge for afib
No
0
0
1.00
1.00
0.00
tPA administered
Yes
4
0
No
0
0
1.00
1.00
0.00
Antithrombotic at
Yes
21
2
48 hours
No
1
2
0.88
0.93
0.57
Cholesterol
Yes
15
0
medication at
discharge
No
0
1
1.00
1.00
1.00
Rehabilitation
Yes
23
1
evaluation
No
0
0
0.96
0.98
0.00
*

Agreement statistics for numerator were calculated when both raters included the record in the indicator population.
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